Reena Shah

2.2k citations
44 papers · 1.3k · 2 hit papers · h-index 13

Impact in

    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research
    • HIV/AIDS drug development and treatment
  • Neurology top 5%
    • Long-Term Effects of COVID-19

Papers in

    • COVID-19 Clinical Research Studies 8
    • SARS-CoV-2 and COVID-19 Research 5
    • HIV/AIDS Research and Interventions 2
    • HIV/AIDS drug development and treatment 2

Reena Shah

38 papers receiving 1.2k citations

Reena Shah's Hit Papers

Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial 2024 · 56 citations
560+2+4Years since publication250500750

Peers

Reena Shah
Comparison fields: 5 of 114
  • Infectious Diseases 612
  • Neurology 277
  • Virology 43
  • Applied Microbiology and Biotechnology 14
  • Critical Care and Intensive Care Medicine 28
Replace Ke Liang with:
Ke Liang China
Enqiang Qin China
Tyler S. Brown United States
Zelalem G. Dessie Ethiopia
Yiyin Chen China
Rachel Baden United States
Roberto Parrella Italy
Pegah Mirzapour Iran
Yongxi Zhang China
Liping Deng China
Reena Shah relative to Ke Liang China Ke Liang's profile →
Citations per field
00.5×4.4×
Ke Liang · 1×
Citations per year

Countries citing papers authored by Reena Shah

Since Specialization
Citations

This map shows the geographic impact of Reena Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reena Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reena Shah more than expected).

Fields of papers citing papers by Reena Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reena Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reena Shah. The network helps show where Reena Shah may publish in the future.

Co-authors

The 25 scholars most cited alongside Reena Shah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Reena Shah Line = papers co-authored together Reena Shah links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Hit paper breakdown →
2020807
2 201463
3
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
Hit paper breakdown →
202456
4 199849
5 199930
6 201626
7 202225
8 201417
9 201115
10 201414
11 202113
12 201913
13 201512
14 202211
15 201311
16 201310
17 20159
18 20229
19 20239
20 20188

About Reena Shah

Reena Shah is a scholar working on Infectious Diseases, Surgery, Health, Pathology and Forensic Medicine and Virology, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Vaccine Coverage and Hesitancy (4 papers), HIV Research and Treatment (3 papers), COVID-19 epidemiological studies (2 papers), Vibrio bacteria research studies (2 papers), HIV/AIDS Research and Interventions (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Infectious Diseases (612 citations), Neurology (277 citations), Virology (43 citations), Applied Microbiology and Biotechnology (14 citations) and Critical Care and Intensive Care Medicine (28 citations). Reena Shah has collaborated with scholars based in Kenya, United States and United Kingdom. Frequent co-authors include Carlos Salama, Gerard J. Criner, Benjamin Krämer, Linda Yau, Jamie Freedman, Jeffrey D. Neidhart, Jian Han, Rachel Baden, Miriam L. Cameron and Julia Garcia‐Diaz. Their work appears in journals such as PLoS ONE, Clinical and Experimental Dermatology, JCO Global Oncology, Cancer Epidemiology Biomarkers & Prevention and Diabetes Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact